These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 31673140)

  • 1. FDA new drug approvals in Q3 2019.
    Urquhart L
    Nat Rev Drug Discov; 2019 Oct; 18(11):816. PubMed ID: 31673140
    [No Abstract]   [Full Text] [Related]  

  • 2. Regulatory watch: FDA new drug approvals in Q3 2018.
    Urquhart L
    Nat Rev Drug Discov; 2018 Oct; 17(11):779. PubMed ID: 30374181
    [No Abstract]   [Full Text] [Related]  

  • 3. Regulatory watch: FDA new drug approvals in Q2 2018.
    Urquhart L
    Nat Rev Drug Discov; 2018 Jul; 17(8):536-537. PubMed ID: 30057412
    [No Abstract]   [Full Text] [Related]  

  • 4. FDA new drug approvals in Q1 2020.
    Urquhart L
    Nat Rev Drug Discov; 2020 May; 19(5):299. PubMed ID: 32296148
    [No Abstract]   [Full Text] [Related]  

  • 5. Top 100 bestselling drugs represent an arena struggling for new FDA approvals: drug age as an efficiency indicator.
    Polanski J; Bogocz J; Tkocz A
    Drug Discov Today; 2015 Nov; 20(11):1300-4. PubMed ID: 26160060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FDA new drug approvals in Q3 2020.
    Urquhart L
    Nat Rev Drug Discov; 2020 Nov; 19(11):746. PubMed ID: 33046853
    [No Abstract]   [Full Text] [Related]  

  • 7. The FDA and the pharmaceutical industry: is regulation contributing to drug shortage?
    Roman A
    Albany Law Rev; 2013-2014; 77(2):539-77. PubMed ID: 24851322
    [No Abstract]   [Full Text] [Related]  

  • 8. New drug and biological product approvals, 2010.
    Traynor K
    Am J Health Syst Pharm; 2011 Feb; 68(3):186, 188, 190. PubMed ID: 21258021
    [No Abstract]   [Full Text] [Related]  

  • 9. Turning a blind eye.
    Nat Med; 2008 Jan; 14(1):1. PubMed ID: 18180702
    [No Abstract]   [Full Text] [Related]  

  • 10. FDA reveals new initiatives to deal with drug shortages.
    McCarthy M
    BMJ; 2013 Nov; 347():f6646. PubMed ID: 24188905
    [No Abstract]   [Full Text] [Related]  

  • 11. FDA new drug approvals in 2009.
    Wynn RL
    Gen Dent; 2010; 58(4):280-4. PubMed ID: 20591770
    [No Abstract]   [Full Text] [Related]  

  • 12. Accelerated approvals under the microscope.
    Mullard A
    Nat Rev Drug Discov; 2021 Jun; 20(6):409-411. PubMed ID: 34012001
    [No Abstract]   [Full Text] [Related]  

  • 13. Market watch: Upcoming catalysts in Q3 2018.
    Nguyen K
    Nat Rev Drug Discov; 2018 Jun; 17(7):461. PubMed ID: 29950705
    [No Abstract]   [Full Text] [Related]  

  • 14. The seduction of biomarkers in the practice of medicine and the tyranny of power in the drug approval process: lessons from niacin.
    Lehmann DF; Sitar DS
    J Clin Pharmacol; 2011 Nov; 51(11):1496-8. PubMed ID: 21998350
    [No Abstract]   [Full Text] [Related]  

  • 15. 2015 FDA drug approvals.
    Mullard A
    Nat Rev Drug Discov; 2016 Feb; 15(2):73-6. PubMed ID: 26837582
    [No Abstract]   [Full Text] [Related]  

  • 16. FDA new drug approvals in Q2 2021.
    Urquhart L
    Nat Rev Drug Discov; 2021 Aug; 20(8):578. PubMed ID: 34267360
    [No Abstract]   [Full Text] [Related]  

  • 17. The FDA's generic-drug approval process: similarities to and differences from brand-name drugs.
    Kefalas CH; Ciociola AA
    Am J Gastroenterol; 2011 Jun; 106(6):1018-21. PubMed ID: 21637264
    [No Abstract]   [Full Text] [Related]  

  • 18. Therapeutic transdermal drug innovation from 2000 to 2014: current status and outlook.
    Walter JR; Xu S
    Drug Discov Today; 2015 Nov; 20(11):1293-9. PubMed ID: 26116094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2008 FDA drug approvals.
    Hughes B
    Nat Rev Drug Discov; 2009 Feb; 8(2):93-6. PubMed ID: 19180096
    [No Abstract]   [Full Text] [Related]  

  • 20. The lag from FDA approval to published cost-utility evidence.
    Chambers JD; Thorat T; Pyo J; Neumann PJ
    Expert Rev Pharmacoecon Outcomes Res; 2015 Jun; 15(3):399-402. PubMed ID: 25579324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.